TABLE 3.

Percentage of people with observed SBP greater than 140 mmHg (OBPM) or greater than 135 mmHg (ABPM or HBPM), who would be diagnosed with ‘hypertension’ according to 2018 ESC/ESH or 2019 NICE guidelines^a

True sysolic BP (mmHg)	Percentage of populationb	Method of Measurement	One set	Two sets	Three sets	Four sets	Five sets
<120	42.3%	OBPMc	0.0%	0.1%	0.1%	0.1%	0.1%
		ABPMd	0.1%	0.2%	0.3%	0.4%	0.5%
		HBPMe	0.1%	0.1%	0.2%	0.3%	0.3%
120--129	12.1%	OBPM	3.1%	6.1%	8.9%	11.5%	14.0%
		ABPM	8.5%	15.9%	22.4%	28.0%	33.0%
		HBPM	7.6%	14.2%	20.0%	25.1%	29.7%
130--39	13.7%	OBPM	24.9%	42.4%	54.9%	64.2%	71.1%
		ABPM	45.5%	68.2%	80.5%	87.6%	91.9%
		HBPM	45.3%	67.8%	79.9%	87.0%	91.4%
≥140	7.7%	OBPM	82.6%	94.3%	97.8%	99.1%	99.6%
		ABPM	93.2%	98.9%	99.8%	100.0%	100.0%
		HBPM	93.8%	99.1%	99.8%	100.0%	100.0%

Data from 2018 ESC/ESH [15] and NICE [17] guidelines.

^aOn the basis of coefficients of variation reported in Warren et al. [15].

^bPercentages do not add to 100% as excludes 24.1% of adult population who are taking BP-lowering medication.

^cOBPM, office BP, one set of measurements is the average of two duplicate clinic measurements, repeated after 6 weeks.

^dABPM, ambulatory BP, one set of measurements is the average of ambulatory BP measurements taken over 12 h (daytime).

^eHBPM, home BP, one set of measurements is the average of two duplicate self-measurements taken twice daily over 6 days.